SCHEMBL25089984

SCHEMBL25089984

CC(C)CN(C)CC(=O)NCCCCCNC(C)C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.36
ALDH1A1 P00352 3/20 0.36
MEN1 O00255 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
EPHX1 P07099 2/20 0.36
CASP2 P42575 1/20 0.35
NAMPT P43490 1/20 0.34
DNM1 Q05193 2/20 0.33
TP53 P04637 1/20 0.33
NAAA Q02083 1/20 0.33
HPGD P15428 1/20 0.33
KDM4E B2RXH2 1/20 0.33
MAPK1 P28482 1/20 0.33
HIF1A Q16665 1/20 0.33
HDAC1 Q13547 2/20 0.31
HDAC2 Q92769 2/20 0.31
HDAC10 Q969S8 2/20 0.31
HDAC8 Q9BY41 2/20 0.31
HDAC6 Q9UBN7 2/20 0.31
MMP8 P22894 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22951202 0.98 KMT2A (0.37) KMT2AALDH1A1MEN1SMN1; SMN2EPHX1
SCHEMBL23589714 0.87 NAMPT (0.39) KMT2AALDH1A1MEN1SMN1; SMN2EPHX1
SCHEMBL22872802 0.87 NAMPT (0.39) KMT2AALDH1A1MEN1SMN1; SMN2EPHX1
SCHEMBL23589671 0.87 NAMPT (0.39) KMT2AALDH1A1MEN1SMN1; SMN2EPHX1
SCHEMBL23589907 0.87 NAMPT (0.39) KMT2AALDH1A1MEN1SMN1; SMN2EPHX1
SCHEMBL23589692 0.87 NAMPT (0.39) KMT2AALDH1A1MEN1SMN1; SMN2EPHX1
SCHEMBL23589715 0.87 NAMPT (0.39) KMT2AALDH1A1MEN1SMN1; SMN2EPHX1
SCHEMBL25101472 0.86 CASP2 (0.51) KMT2AMEN1EPHX1CASP2DNM1
SCHEMBL25089986 0.86 MEN1 (0.41) KMT2AALDH1A1MEN1SMN1; SMN2EPHX1
SCHEMBL21227614 0.86 CASP2 (0.51) KMT2AMEN1EPHX1CASP2DNM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230065463-A1 COMPOUNDS AND USES THEREOF FOGHORN THERAPEUTICS INC. 2023-03-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230065463-A1 COMPOUNDS AND USES THEREOF VHL, TFEB, BECN1 KMT2A 682/4885ALDH1A1 1358/4885MEN1 1032/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.